Q fever poses a worldwide health challenge. Equipped with a team of proficient researchers and scientists well-versed in Q fever, our company is dedicated to the advancement of sophisticated in vitro diagnostic (IVD) solutions. Our services encompass point-of-care testing and companion diagnostic development to accelerate the diagnostic timeline and customize therapeutic strategies for Q fever.
Introduction to Q Fever
Q fever, stemming from the bacterium Coxiella burnetii, is a zoonotic illness impacting both humans and animals. The transmission of Q fever to humans primarily occurs through inhalation of contaminated aerosols or through contact with infected animals or their products. The disease manifests with a wide range of symptoms, from flu-like illness to severe complications such as pneumonia, hepatitis, and endocarditis.
Fig. 1 Symptoms and stages of Q fever in humans. (Sahu, Radhakrishna, et al., 2021)
Diagnostic Biomarkers for Q Fever
Q fever presents a diagnostic challenge due to its varied clinical manifestations. The identification of dependable biomarkers is crucial for the precise and prompt detection of Q fever. These biomarkers are quantifiable signals that can suggest the existence of a disease or infection within the body.
IgM and IgG Antibodies
Antibodies against Coxiella burnetii antigens serve as prevalent diagnostic indicators for Q fever. Immunoglobulin M (IgM) antibodies are usually detected during acute infection, whereas immunoglobulin G (IgG) antibodies may persist in chronic cases.
Bacterial DNA
Genetic indicators such as bacterial DNA are widely utilized as diagnostic biomarkers. The identification of Coxiella burnetii DNA in samples through molecular techniques like PCR can furnish direct confirmation of infection, thereby assisting in early diagnosis.
IVD Kits for Q Fever
In vitro diagnostic (IVD) kits are often designed based on diagnostic biomarkers for Q fever. These kits enable healthcare providers to quickly identify the presence of Coxiella burnetii in a sample, facilitating timely initiation of suitable therapeutics and averting the progression of Q fever into more severe manifestations.
Coxiella Burnetii Antibody Test Kits
Designed to detect antibodies like IgM and IgG directed against Coxiella burnetii in samples, these kits play a pivotal role in diagnosing both acute and chronic Q fever infections. Typically assessed via ELISA, they offer high specificity and sensitivity, ensuring the delivery of reliable results.
Coxiella Burnetii DNA Test Kits
Test kits for Coxiella burnetii DNA employ molecular methods like polymerase chain reaction (PCR) to identify the pathogen's genetic material in a sample. By conducting DNA analysis, these kits offer direct confirmation of infection, enabling prompt initiation of therapeutics.
Our Services
As a frontrunner in Q fever diagnostic development, our company offers inclusive IVD solutions tailored to intricate diagnostic requirements. Specializing in crafting DNA or antibody detection reagents/kits for Coxiella burnetii infection, we aim to facilitate early detection and precise diagnosis of this rare infectious disease. Leveraging state-of-the-art molecular diagnostic devices, we work towards streamlining and automating diagnostic procedures to enhance efficacy.
Acknowledging the significance of point-of-care testing (POCT) in settings with limited resources, our researchers specialize in creating swift diagnostic assays for immediate Q fever identification on-site. Our companion diagnostic development services concentrate on integrating diagnostic assays with tailored therapies to facilitate personalized Q fever management.
If you are interested in our services, please don't hesitate to reach out to us for further information and pricing details on the services we offer.
Reference
- Sahu, Radhakrishna, et al. "Current perspectives on the occurrence of Q fever: highlighting the need for systematic surveillance for a neglected zoonotic disease in Indian subcontinent." Environmental Microbiology Reports 13.2 (2021): 138-158.
All of our services and products are intended for preclinical research use
only and cannot be used to diagnose, treat or manage patients.
